Treatment patterns and outcomes of patients with CNS involvement of blastic plasmacytoid dendritic cell neoplasm (BPDCN)

Leuk Lymphoma. 2022 Nov;63(11):2757-2759. doi: 10.1080/10428194.2022.2090552. Epub 2022 Jun 21.

Authors

Affiliations

¹ Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.
² Duke Cancer Institute, Durham, NC, USA.
³ Medical Oncology, Dana Farber - Harvard Institute, Boston, MA, USA.
⁴ University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA.
⁵ Division of Hematology, The Ohio State University, Columbus, OH, USA.

PMID: 35727174
DOI: 10.1080/10428194.2022.2090552

No abstract available

Publication types

Letter

MeSH terms

Central Nervous System Neoplasms* / diagnosis
Central Nervous System Neoplasms* / therapy
Dendritic Cells
Hematologic Neoplasms* / diagnosis
Hematologic Neoplasms* / therapy
Humans
Myeloproliferative Disorders*
Skin Neoplasms*